Danaher Corporation

(DHR) Trade

By |

Profile

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.

Contact Information

Website: www.danaher.com
Email: investor.relations@danaher.com
Main Phone: +1 202 828-0850
Address: 2200 Pennsylvania Avenue, North West
Address 2: Suite 800W
State: DC
City / Town: Washington
Country: USA
Postal Code: 20037-1701

Issuer Information

Exchange: NYE
CEO: Thomas P. Joyce
Employees: 71000
NAICS: Medical Laboratories(621511)

Equities News

View More

Profile

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.

Contact Information

Website: www.danaher.com
Email: investor.relations@danaher.com
Main Phone: +1 202 828-0850
Address: 2200 Pennsylvania Avenue, North West
Address 2: Suite 800W
State: DC
City / Town: Washington
Country: USA
Postal Code: 20037-1701

Issuer Information

Exchange: NYE
CEO: Thomas P. Joyce
Employees: 71000
NAICS: Medical Laboratories(621511)

Equities News

View More
$ 142.99 $ 6.84 (5.02%)
Last Price 142.99 Change $ 6.84 Change % 5.02 Tick N/A
Bid 142.99 Bid Size 200.00 Ask 145.00 Ask Size 100.00
Open 139.26 High 143.03 Low 138.97 Prev Close 136.15
Last Trade Volume 13.7 mi 52 Wk Hi 147.33 52 Wk Low 94.59
Market Cap 102.7 bi Ex-Div Date Div Rate 0.68 Yield 0.4760
Shares 718,281,174.00 EPS (TTM) 3.38 PE Ratio 39.80 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 38 121
Number of Buys 30 60
Number of Sells 8 61
Net Activity 69015 152954
Last 10 Buys Shares
Donald J. Ehrlich 1,000
Elias A. Zerhouni 1,000
Linda Hefner Filler 1,000
Last 10 Sell Shares
Linda Hefner Filler 1,000
Linda Hefner Filler 1,000
Daniel L. Comas 1,000
Daniel L. Comas 1,000
Daniel L. Comas 1,000
Thomas P. Joyce 1,000
Thomas P. Joyce 1,000
Thomas P. Joyce 1,000
Rainer M. Blair 1,000
John T. Schwieters 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 120 120 120 120
Low Target Price Estimate 96 96 96 96
Mean Target Price Estimate 110.36 110.36 110.36 110.36
Standard Deviation 6.22 6.22 6.22 6.22
Date of Most Recent Estimate 04/23/18 04/23/18 04/23/18 04/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 12 12 12 12
Moderate Buy 1 1 1 1
Hold 2 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.3 1.3 1.41 1.5